These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 17489784

  • 1. Remission in autoimmune hepatitis: what is it, and can it ever be achieved?
    Al-Chalabi T, Heneghan MA.
    Am J Gastroenterol; 2007 May; 102(5):1013-5. PubMed ID: 17489784
    [Abstract] [Full Text] [Related]

  • 2. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
    Montano-Loza AJ, Carpenter HA, Czaja AJ.
    Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
    [Abstract] [Full Text] [Related]

  • 3. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A.
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [Abstract] [Full Text] [Related]

  • 4. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis.
    Czaja AJ, Menon KV, Carpenter HA.
    Hepatology; 2002 Apr; 35(4):890-7. PubMed ID: 11915036
    [Abstract] [Full Text] [Related]

  • 5. Clinical subgroup of autoimmune hepatitis type 1 sustaining remission without additional drugs.
    Ohana M, Hajiro K, Okazaki K, Haga H, Kobashi Y.
    Hepatogastroenterology; 1998 Apr; 45(23):1667-72. PubMed ID: 9840126
    [Abstract] [Full Text] [Related]

  • 6. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
    Banerjee S, Rahhal R, Bishop WP.
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959
    [Abstract] [Full Text] [Related]

  • 7. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G, Vergani D.
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis and treatment of autoimmune hepatitis].
    Verwer BJ, Bouma G, Bloemena E, Schreuder TC, Mulder CJ, van Nieuwkerk KM.
    Ned Tijdschr Geneeskd; 2009 Aug; 153():A247. PubMed ID: 19900315
    [Abstract] [Full Text] [Related]

  • 9. Early treatment response predicts the need for liver transplantation in autoimmune hepatitis.
    Tan P, Marotta P, Ghent C, Adams P.
    Liver Int; 2005 Aug; 25(4):728-33. PubMed ID: 15998422
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
    Montano-Loza AJ, Carpenter HA, Czaja AJ.
    Hepatology; 2007 Oct; 46(4):1138-45. PubMed ID: 17668882
    [Abstract] [Full Text] [Related]

  • 13. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.
    van Gerven NM, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ, Beuers U, van Buuren HR, de Man RA, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Mulder CJ, van Nieuwkerk KM, Bouma G, Dutch Autoimmune Hepatitis Working Group.
    J Hepatol; 2013 Jan; 58(1):141-7. PubMed ID: 22989569
    [Abstract] [Full Text] [Related]

  • 14. Consequences of treatment withdrawal in type 1 autoimmune hepatitis.
    Montano-Loza AJ, Carpenter HA, Czaja AJ.
    Liver Int; 2007 May; 27(4):507-15. PubMed ID: 17403191
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis.
    Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse AW, Schramm C.
    J Hepatol; 2015 Mar; 62(3):642-6. PubMed ID: 25457202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.
    Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, Baldo V, Premoli A, Olivero F, Morello E, Durazzo M.
    Aliment Pharmacol Ther; 2006 Oct 01; 24(7):1051-7. PubMed ID: 16984499
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.